Table 1. The correlation between clinicopathological features and miR-27a-3p expression in HCC patients.

Clinical characteristics	Expression				χ2	P-value
	Low		High
	186	50.00%	186	50.00%
Age (years)
≤60	86	23.10%	91	24.50%	0.269	0.604
>60	100	26.90%	95	25.50%
Gender
Female	56	15.10%	63	16.90%	0.605	0.437
Male	130	34.90%	123	33.10%
Race
White	79	21.20%	103	27.70%	6.196	0.013*
No-white	107	28.80%	83	22.30%
T stage
T1–2	147	39.50%	132	35.50%	3.226	0.072
T3–4	39	10.50%	54	14.50%
N stage
N0	161	43.30%	170	45.70%	2.220	0.136
N1	25	6.70%	16	4.30%
M stage
M0	159	42.70%	172	46.20%	4.633	0.031*
M1	27	7.30%	14	3.80%
Differentiation grade
G1–2	117	31.50%	118	31.70%	0.012	0.914
G3–4	69	18.50%	68	18.30%
Child–Pugh
Grade A	134	36.00%	160	43.00%	10.966	0.001*
Grade B–C	52	14.00%	26	7.00%
Tumor stage
I–II	113	30.40%	112	30.10%	0.011	0.916
III–IV	73	19.60%	74	19.90%

^*P<0.05.